A deep-learning algorithm trained with brain MRI scans of AQP4-IgG+ NMOSD and MS patients was also validated to be able to forecast whether seronegative NMOSD-like manifestations would be developed into antibody-positive NMOSD or MS or stay DN NMOSD.41 Here, AQP4 is linked to myeloid sarcoma.